Alyeska Investment Group
EVH icon

Alyeska Investment Group’s Evolent Health EVH Stock Holding History

Alyeska Investment Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-250,000
Closed -$4.45M – 462
2017
Q3 		$4.45M Buy
250,000
+199,300
+393% +$4.11M 0.03% 300
2017
Q2 		$1.28M Sell
50,700
-86,000
-63% -$2.07M 0.01% 386
2017
Q1 		$3.05M Sell
136,700
-513,300
-79% -$9.85M 0.02% 360
2016
Q4 		$9.62M Buy
650,000
+147,400
+29% +$2.9M 0.08% 280
2016
Q3 		$12.4M Buy
+502,600
New +$11.7M 0.11% 237
2015
Q3 		– Sell
-70,000
Closed -$1.36M – 484
2015
Q2 		$1.36M Buy
+70,000
New +$1.3M 0.02% 384

Other funds holding EVH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
FG
Formula Growth Montreal, Quebec, Canada $222M AUM 27.84% 1-Year Est. Return

Alyeska Investment Group's EVH Position: Q4 2017 in Review

Alyeska Investment Group sold out of Evolent Health (EVH) in Q4 2017, closing a stake of 250,000 shares — an estimated $4.45M sold.

Alyeska Investment Group first reported a position in EVH in Q2 2015 and held it in 6 quarters. The position peaked at $12.4M in Q3 2016. 156 funds tracked by Wall St. Rank hold EVH as of Q4 2017.

  • Alyeska Investment Group reported no remaining Evolent Health position as of Q4 2017 after selling out during the quarter.
  • Alyeska Investment Group sold 250,000 Evolent Health shares in Q4 2017, an estimated $4.45M.
  • Alyeska Investment Group first reported a position in Evolent Health in Q2 2015 and held it in 6 quarters.
  • Alyeska Investment Group's Evolent Health position peaked at $12.4M in Q3 2016.
  • 156 funds tracked by Wall St. Rank held Evolent Health as of Q4 2017.

Based on Alyeska Investment Group's 13F filing for Q4 2017, filed 14 Feb 2018.